NASDAQ:XLO | Profit Breakdown | Xilio Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$18.69M-$3.49M-$6.37M
2026-03-31$12.65M-$14.11M-$9.53M
2025-12-31$13.69M-$11.84M$10.36M
2025-09-30$19.07M-$1.93M-$16.29M
2025-06-30$8.08M-$14.37M-$15.84M
2025-03-31$2.93M-$13.85M-$13.27M
2024-12-31$1.72M-$13.63M-$13.09M
2024-09-30$2.26M-$14.76M-$14.02M
2024-06-30$2.36M-$14.7M-$13.93M
2024-03-31-$17.49M-$17.2M
2023-12-31-$18.13M-$17.66M
2023-09-30-$17.36M-$16.75M
2023-06-30-$20.12M-$19.36M
2023-03-31-$23.53M-$22.65M
2022-12-31-$23.17M-$22.47M
2022-09-30-$20.21M-$19.79M
2022-06-30-$24.55M-$24.61M
2022-03-31-$21.22M-$21.35M
2021-12-31-$19.56M-$19.7M
2021-09-30-$15.96M-$16.25M
2021-06-30-$23.01M-$23.18M
2021-03-31-$16.52M-$16.67M
2020-12-31-$20.6M-$20.77M
2020-09-30-$14.62M-$14.82M
2020-06-30-$11.51M
2020-03-31-$8.12M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$43.77M-$41.98M-$35.04M-$35.04M
2024-12-31$6.34M-$60.58M-$58.24M-$58.24M
2023-12-31-$79.13M-$76.4M
2022-12-31-$89.15M-$88.22M
2021-12-31-$75.04M-$75.8M
2020-12-31-$54.56M-$55.22M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.